Is CLGN research on Rallies investment advice?

No. Rallies provides research, data, and educational context for CLGN. It does not provide personalized investment advice.

CLGN (CollPlant Biotechnologies Ltd Ordinary Shares) Stock Analysis - Financials

CollPlant Biotechnologies Ltd Ordinary Shares (CLGN) is a publicly traded Healthcare sector company. As of September 20, 2026, CLGN trades at $4.54 with a market cap of $8.62M and a P/E ratio of 0.00. CLGN moved +12.26% today. Year to date, CLGN is -67.43%; over the trailing twelve months it is -82.73%. Its 52-week range spans $2.64 to $49.80. Rallies surfaces CLGN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are CLGN's key financials?

CLGN financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. CLGN recently traded at $4.54. Market cap is $8.62M. P/E ratio is 0.00. Revenue is $0.

CLGN Key Metrics

Key financial metrics for CLGN
Metric	Value
Price	$4.54
Market Cap	$8.62M
P/E Ratio	0.00
EPS	$0.00
Dividend Yield	0.00%
52-Week High	$49.80
52-Week Low	$2.64
Volume	153.09K
Avg Volume	0
Revenue (TTM)	$0
Net Income	$0
Gross Margin	0.00%

CLGN Analyst Consensus

CLGN analyst coverage data. Average price target: $0.00.

Common questions about CLGN

What are CLGN's key financials?: CLGN financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. CLGN recently traded at $4.54. Market cap is $8.62M. P/E ratio is 0.00. Revenue is $0.
Is CLGN research on Rallies investment advice?: No. Rallies provides research, data, and educational context for CLGN. It does not provide personalized investment advice.